TRADING QUOTES       CLICK ON A TAB BELOW: (Business Combination or IPO Details) to access the relevant details.  Additional info below.  PROPOSED BUSINESS COMBINATION:  IMMUNOVANT SCIENCES, LTD. ESTIMATED CURRENT FUNDS in TRUST: $116.3 Million*CURRENT PER SHARE REDEMPTION PRICE: $10.12*EQUITY VALUE: $555.8 *SPACInsider estimate a/o 12-13-19 Health Sciences Acquisitions Corp. proposes to merge with
Read More
To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.